Global Biobanking Market Size, Trends and Growth Opportunity, By Product and Services (Equipment, Consumables, Service, and Software), By Sample Type (Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products), By Storage Type (Manual Storage and Automated Storage), By Type of Biobank (Population based Biobanks and Disease- Oriented Biobanks), By Ownership (National/Regional Agencies, Nonprofit Organization, University, and Private), By Application (Regenerative Medicine, Life Science Research, and Clinical Research), By Region and Forecast Till 2030.

Report ID : AMR1004368 | Industries : Healthcare | Published On :December 2023 | Page Count : 226

The Global Biobanking Market was valued at USD 2.76 billion in 2022 and it is expected to reach USD 5.34 billion in 2030 at a CAGR of 4.34 % during forecast period 2023-2030.

The Russia-Ukraine Conflict, High Inflation, and Cumulative Impact of COVID-19 are anticipated to have a significant long-term impact on the Global Biobanking Market. The ongoing research takes into consideration how the pandemic has affected consumer behavior, supply chain disruptions, and governmental initiatives. The research report focuses on the ongoing economic and political upheaval in Eastern Europe led by the Russia-Ukraine Conflict, as well as the potential impacts it may have on the demand-supply balances, pressure on pricing variations, and import-export and trading. The research report additionally addresses the impacts of high inflation on the world economy and provides an overview of the fiscal measures taken to monitor and minimize the effects of high inflation on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

The Global Biobanking Market can be classified into the following segments in order to forecast sales and examine trends:

• Based on Product and Services, the biobanking market is classified into the Equipment, Consumables, Service, and Software.
• Based on Sample Type, the market is classified into Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products.
• Based on Storage Type, the market is classified into Manual Storage and Automated Storage.
• Based on Type of Biobank, the market is classified into Population based Biobanks and Disease- Oriented Biobanks.
• Based on Ownership, the market is classified into National/Regional Agencies, Nonprofit Organization, University, and Private.
• Based on Application, the market is classified into Regenerative Medicine, Life Science Research, and Clinical Research.
• Based on Region, the market is studied across North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The North America Americas is further divided into the United States, Canada, and Mexico. Europe is further bifurcated into Germany, UK, France, Russia, Italy, Spain and Rest of Europe. The Asia-Pacific region is further segmented into China, India, Japan, South Korea, Australia, Malaysia, Singapore, New Zealand, and Rest of Asia-Pacific. The countries in the Latin American region include Brazil, Argentina, Peru, Chile, Colombia, Venezuela and Rest of Latin America. The Middle East and African region is classified into Saudi Arabia, UAE, Kuwait, Egypt, Kuwait and Rest of Middle East and Africa.

Competitive Landscape:

The competitive landscape analysis in the biobanking market involves a comprehensive assessment of key market players, their market share, product offerings, recent developments, strategies, partnerships, and mergers/acquisitions. This analysis provides valuable insights into the competitive dynamics and helps stakeholders understand the position of each player in the market. A SWOT analysis (Strengths, Weaknesses, Opportunities, and Threats) is conducted for each major player to assess their internal capabilities, vulnerabilities, and external market factors that impact their competitiveness. This analysis helps to identify the competitive advantages and areas for improvement for each player.
Overall, the competitive landscape analysis provides a holistic view of the biobanking market, highlighting the key players, their market share, product offerings, recent developments, strategies, and SWOT analysis. This information assists stakeholders in making informed decisions, formulating effective strategies, and identifying potential partnerships or investment opportunities.

Key Players:

The research report thoroughly analyses the most significant recent advancements by the top players and innovation profiles in the global biobanking market, comprising: Thermo Fisher Scientific Inc, Tecan Trading AG, QIAGEN, Hamilton Company., Brooks Life Sciences, TTP Labtech, VWR International, LLC, Promega Corporation, Worthington Industries, BD, Merck KGaA, Biokryo GmbH, Cell&Co BioServices, RUCDR Infinite Biologics, Modul-Bio, STEMCELL Technologies Inc, BioLifeSolutions Inc., BioCision., and Taylor-Wharton.

Regional Analysis:

The analysis includes important geographic areas like North America, Europe, Asia Pacific, and the rest of the world. For important markets within each area, it might also contain analysis at the country level. This analysis throws light on the market dynamics, trends, and opportunities unique to various geographical areas. With the aid of the regional analysis, stakeholders can better understand the regional variations in the market for biobanking, allowing them to modify their plans and investments in accordance with the unique market dynamics and opportunities in each region.

The report offers insights on the following guidelines:

1. Market Penetration: Major players offer detail information on the market.
2. Market Development: Examines market penetration in mature market sectors and provides in-depth information regarding potential new markets.
3. Market Diversification: Contains comprehensive information on newly released products, undeveloped regions, current events, and investments
4. Market Trends: Provides an in-depth analysis of the impact of COVID-19 cumulatively, Cumulative Impact due to Nearing Economic Downturn, the conflict in Russia and Ukraine, and the high inflation rate.
5. Competitive Assessment & Intelligence: Offers a thorough analysis of the market shares, business plans, goods, certifications, legal permits, patent landscape, and manufacturing prowess of the major companies.
6. Product Development & Innovation: Offers analytical perspectives on emerging technologies, R&D initiatives, and ground-breaking product developments.

The report answers questions such as:

What is the market size and forecast of the Global Biobanking Market?
What are the limiting factors and impact of COVID-19 shaping the Global Biobanking Market during the forecast period?
Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biobanking Market?
What is the competitive strategic window for opportunities in the Global Biobanking Market?
What are the technology trends and regulatory frameworks in the Global Biobanking Market?
What is the market share of the leading vendors in the Global Biobanking Market?
What entry strategies and modalities are deemed appropriate for the Global Biobanking Market?

Frequently Asked Questions (FAQ) regarding the Global Biobanking Market:

What is the anticipated size of the global market for biobanking?
What is the market size for biobanking globally?
What is the projected size of the global market for biobanking?
Who are the most prominent companies in the global market for biobanking?

Global Biobanking Market

1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Biobanking Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Biobanking Market, By Product and Services
5.1 Y-o-Y Growth Comparison, By Product and Services
5.2 Global Biobanking Market Share Analysis, By Product and Services
5.3 Global Biobanking Market Size and Forecast, By Product and Services
5.3.1 Equipment
5.3.2 Consumables
5.3.3 Service
5.3.4 Software
6 Global Biobanking Market, By Type of Biobank Type
6.1 Y-o-Y Growth Comparison, By Type of Biobank Type
6.2 Global Biobanking Market Share Analysis, By Type of Biobank Type
6.3 Global Biobanking Market Size and Forecast, By Type of Biobank Type
6.3.1 Blood Products
6.3.2 Human Tissue
6.3.3 Cell Lines
6.3.4 Nucleic Acids
6.3.5 Biological Fluids
6.3.6 Human Waste Products
7 Global Biobanking Market, By Storage Type
7.1 Y-o-Y Growth Comparison, By Storage Type
7.2 Global Biobanking Market Share Analysis, By Storage Type
7.3 Global Biobanking Market Size and Forecast, By Storage Type
7.3.1 Manual Storage
7.3.2 Automated Storage
8 Global Biobanking Market, By Type of Biobank
8.1 Y-O-Y Growth Comparison, By Type of Biobank
8.2 Global Biobanking Market Share Analysis, By Type of Biobank
8.3 Global Biobanking Market Size and Forecast, By Type of Biobank
8.3.1 Population based Biobanks
8.3.2 Disease- Oriented Biobanks
9 Global Biobanking Market, By Ownership
9.1 Y-O-Y Growth Comparison, By End-User
9.2 Global Biobanking Market Share Analysis, By End-User
9.3 Global Biobanking Market Size and Forecast, By End-User
9.3.1 National/Regional Agencies
9.3.2 Hospitals
9.3.3 Nonprofit Organization
9.3.4 University
9.3.5 Private
10 Global Biobanking Market, By Application
10.1 Y-O-Y Growth Comparison, By Application
10.2 Global Biobanking Market Share Analysis, By Application
10.3 Global Biobanking Market Size and Forecast, By Application
10.3.1 Regenerative Medicine
10.3.2 Life Science Research
10.3.3 Clinical Research
11 Global Biobanking Market, By Region
11.1 Global Biobanking Market Share Analysis, By Region
11.2 Global Biobanking Market Share Analysis, By Region
11.3 Global Biobanking Market Size and Forecast, By Region
12 North America Biobanking Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 North America Biobanking Market Share Analysis, ByProduct and Services
12.3 North America Biobanking Market Size and Forecast, By Type of Biobank Type
12.4 North America Biobanking Market Size and Forecast, By Storage Type
12.5 North America Biobanking Market Size and Forecast, By Type of Biobank
12.6 North America Biobanking Market Size and Forecast, By End-Use
12.7 North America Biobanking Market Size and Forecast, By Application
12.8 North America Biobanking Market Size and Forecast, By Country
12.8.1 U.S.
12.8.1.1 Market Size and Forecast, ByProduct and Services
12.8.1.2 Market Size and Forecast, By Type of Biobank Type
12.8.1.3 Market Size and Forecast, By Storage Type
12.8.1.4 Market Size and Forecast, By Type of Biobank
12.8.1.5 Market Size and Forecast, By End-Use
12.8.1.6 Market Size and Forecast, By Application
12.8.2 Canada
12.8.2.1 Market Size and Forecast, ByProduct and Services
12.8.2.2 Market Size and Forecast, By Type of Biobank Type
12.8.2.3 Market Size and Forecast, By Storage Type
12.8.2.4 Market Size and Forecast, By Type of Biobank
12.8.2.5 Market Size and Forecast, By End-Use
12.8.2.6 Market Size and Forecast, By Application
12.8.3 Mexico
12.8.3.1 Market Size and Forecast, ByProduct and Services
12.8.3.2 Market Size and Forecast, By Type of Biobank Type
12.8.3.3 Market Size and Forecast, By Storage Type
12.8.3.4 Market Size and Forecast, By Type of Biobank
12.8.3.5 Market Size and Forecast, By End-Use
12.8.3.6 Market Size and Forecast, By Application
13 Europe Biobanking Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Europe Biobanking Market Share Analysis, ByProduct and Services
13.3 Europe Biobanking Market Size and Forecast, By Type of Biobank Type
13.4 Europe Biobanking Market Size and Forecast, By Storage Type
13.5 Europe Biobanking Market Size and Forecast, By Type of Biobank
13.6 Europe Biobanking Market Size and Forecast, By End-User
13.7 Europe Biobanking Market Size and Forecast, By Application
13.8 Europe Biobanking Market Size and Forecast, By Country
13.8.1 Germany
13.8.1.1 Market Size and Forecast, ByProduct and Services
13.8.1.2 Market Size and Forecast, By Type of Biobank Type
13.8.1.3 Market Size and Forecast, By Storage Type
13.8.1.4 Market Size and Forecast, By Type of Biobank
13.8.1.5 Market Size and Forecast, By End-Use
13.8.1.6 Market Size and Forecast, By Application
13.8.2 France
13.8.2.1 Market Size and Forecast, ByProduct and Services
13.8.2.2 Market Size and Forecast, By Type of Biobank Type
13.8.2.3 Market Size and Forecast, By Storage Type
13.8.2.4 Market Size and Forecast, By Type of Biobank
13.8.2.5 Market Size and Forecast, By End-Use
13.8.2.6 Market Size and Forecast, By Application
13.8.3 UK
13.8.3.1 Market Size and Forecast, ByProduct and Services
13.8.3.2 Market Size and Forecast, By Type of Biobank Type
13.8.3.3 Market Size and Forecast, By Storage Type
13.8.3.4 Market Size and Forecast, By Type of Biobank
13.8.3.5 Market Size and Forecast, By End-Use
13.8.3.6 Market Size and Forecast, By Application
13.8.4 Russia
13.8.4.1 Market Size and Forecast, ByProduct and Services
13.8.4.2 Market Size and Forecast, By Type of Biobank Type
13.8.4.3 Market Size and Forecast, By Storage Type
13.8.4.4 Market Size and Forecast, By Type of Biobank
13.8.4.5 Market Size and Forecast, By End-Use
13.8.4.6 Market Size and Forecast, By Application
13.8.5 Italy
13.8.5.1 Market Size and Forecast, ByProduct and Services
13.8.5.2 Market Size and Forecast, By Type of Biobank Type
13.8.5.3 Market Size and Forecast, By Storage Type
13.8.5.4 Market Size and Forecast, By Type of Biobank
13.8.5.5 Market Size and Forecast, By End-Use
13.8.5.6 Market Size and Forecast, By Application
13.8.6 Spain
13.8.6.1 Market Size and Forecast, ByProduct and Services
13.8.6.2 Market Size and Forecast, By Type of Biobank Type
13.8.6.3 Market Size and Forecast, By Storage Type
13.8.6.4 Market Size and Forecast, By Type of Biobank
13.8.6.5 Market Size and Forecast, By End-Use
13.8.6.6 Market Size and Forecast, By Application
13.8.7 Rest of Europe
13.8.7.1 Market Size and Forecast, ByProduct and Services
13.8.7.2 Market Size and Forecast, By Type of Biobank Type
13.8.7.3 Market Size and Forecast, By Storage Type
13.8.7.4 Market Size and Forecast, By Type of Biobank
13.8.7.5 Market Size and Forecast, By End-Use
13.8.7.6 Market Size and Forecast, By Application
14 Asia Pacific Biobanking Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Asia Pacific Biobanking Market Share Analysis, ByProduct and Services
14.3 Asia Pacific Biobanking Market Size and Forecast, By Type of Biobank Type
14.4 Asia Pacific Biobanking Market Size and Forecast, By Storage Type
14.5 Asia Pacific Biobanking Market Size and Forecast, By Type of Biobank
14.6 Asia Pacific Biobanking Market Size and Forecast, By End-User
14.7 Asia Pacific Biobanking Market Size and Forecast, By Application
14.8 Asia Pacific Biobanking Market Size and Forecast, By Country
14.8.1 China
14.8.1.1 Market Size and Forecast, ByProduct and Services
14.8.1.2 Market Size and Forecast, By Type of Biobank Type
14.8.1.3 Market Size and Forecast, By Storage Type
14.8.1.4 Market Size and Forecast, By Type of Biobank
14.8.1.5 Market Size and Forecast, By End-Use
14.8.1.6 Market Size and Forecast, By Application
14.8.2 Japan
14.8.2.1 Market Size and Forecast, ByProduct and Services
14.8.2.2 Market Size and Forecast, By Type of Biobank Type
14.8.2.3 Market Size and Forecast, By Storage Type
14.8.2.4 Market Size and Forecast, By Type of Biobank
14.8.2.5 Market Size and Forecast, By End-Use
14.8.2.6 Market Size and Forecast, By Application
14.8.3 India
14.8.3.1 Market Size and Forecast, ByProduct and Services
14.8.3.2 Market Size and Forecast, By Type of Biobank Type
14.8.3.3 Market Size and Forecast, By Storage Type
14.8.3.4 Market Size and Forecast, By Type of Biobank
14.8.3.5 Market Size and Forecast, By End-Use
14.8.3.6 Market Size and Forecast, By Application
14.8.4 South Korea
14.8.3.1 Market Size and Forecast, ByProduct and Services
14.8.3.2 Market Size and Forecast, By Type of Biobank Type
14.8.3.3 Market Size and Forecast, By Storage Type
14.8.3.4 Market Size and Forecast, By Type of Biobank
14.8.3.5 Market Size and Forecast, By End-Use
14.8.3.6 Market Size and Forecast, By Application
14.8.5 Australia
14.8.5.1 Market Size and Forecast, ByProduct and Services
14.8.5.2 Market Size and Forecast, By Type of Biobank Type
14.8.5.3 Market Size and Forecast, By Storage Type
14.8.5.4 Market Size and Forecast, By Type of Biobank
14.8.5.5 Market Size and Forecast, By End-Use
14.8.5.6 Market Size and Forecast, By Application
14.8.6 New Zealand
14.8.6.1 Market Size and Forecast, ByProduct and Services
14.8.6.2 Market Size and Forecast, By Type of Biobank Type
14.8.6.3 Market Size and Forecast, By Storage Type
14.8.6.4 Market Size and Forecast, By Type of Biobank
14.8.6.5 Market Size and Forecast, By End-Use
14.8.6.6 Market Size and Forecast, By Application
14.8.7 Singapore
14.8.7.1 Market Size and Forecast, ByProduct and Services
14.8.7.2 Market Size and Forecast, By Type of Biobank Type
14.8.7.3 Market Size and Forecast, By Storage Type
14.8.7.4 Market Size and Forecast, By Type of Biobank
14.8.7.5 Market Size and Forecast, By End-Use
14.8.7.6 Market Size and Forecast, By Application
14.8.8 Malaysia
14.8.8.1 Market Size and Forecast, ByProduct and Services
14.8.8.2 Market Size and Forecast, By Type of Biobank Type
14.8.8.3 Market Size and Forecast, By Storage Type
14.8.8.4 Market Size and Forecast, By Type of Biobank
14.8.8.5 Market Size and Forecast, By End-Use
14.8.8.6 Market Size and Forecast, By Application
14.8.9. Rest of Asia
14.8.9.1 Market Size and Forecast, ByProduct and Services
14.8.9.2 Market Size and Forecast, By Type of Biobank Type
14.8.9.3 Market Size and Forecast, By Storage Type
14.8.9.4 Market Size and Forecast, By Type of Biobank
14.8.9.5 Market Size and Forecast, By End-Use
14.8.9.6 Market Size and Forecast, By Application
15 Latin America Biobanking Market Analysis and Forecast (2023-2030)
15.1 Introduction
15.2 Latin America Biobanking Market Share Analysis, ByProduct and Services
15.3 Latin America Biobanking Market Size and Forecast, By Type of Biobank Type
15.4 Latin America Biobanking Market Size and Forecast, By Storage Type
15.5 Latin America Biobanking Market Size and Forecast, By Type of Biobank
15.6 Latin America Biobanking Market Size and Forecast, By End-User
15.7 Latin America Biobanking Market Size and Forecast, By Application
15.8 Latin America Biobanking Market Size and Forecast, Country
15.8.1. Brazil
15.8.1.1 Market Size and Forecast, ByProduct and Services
15.8.1.2 Market Size and Forecast, By Type of Biobank Type
15.8.1.3 Market Size and Forecast, By Storage Type
15.8.1.4 Market Size and Forecast, By Type of Biobank
15.8.1.5 Market Size and Forecast, By End-Use
15.8.1.6 Market Size and Forecast, By Application
15.8.2 Argentina
15.8.2.1 Market Size and Forecast, ByProduct and Services
15.8.2.2 Market Size and Forecast, By Type of Biobank Type
15.8.2.3 Market Size and Forecast, By Storage Type
15.8.2.4 Market Size and Forecast, By Type of Biobank
15.8.2.5 Market Size and Forecast, By End-Use
15.8.2.6 Market Size and Forecast, By Application
15.8.3 Colombia
15.8.3.1 Market Size and Forecast, ByProduct and Services
15.8.3.2 Market Size and Forecast, By Type of Biobank Type
15.8.3.3 Market Size and Forecast, By Storage Type
15.8.3.4 Market Size and Forecast, By Type of Biobank
15.8.3.5 Market Size and Forecast, By End-Use
15.8.3.6 Market Size and Forecast, By Application
15.8.4 Peru
15.8.4.1 Market Size and Forecast, ByProduct and Services
15.8.4.2 Market Size and Forecast, By Type of Biobank Type
15.8.4.3 Market Size and Forecast, By Storage Type
15.8.4.4 Market Size and Forecast, By Type of Biobank
15.8.4.5 Market Size and Forecast, By End-Use
15.8.4.6 Market Size and Forecast, By Application
15.8.5 Chile
15.8.5.1 Market Size and Forecast, ByProduct and Services
15.8.5.2 Market Size and Forecast, By Type of Biobank Type
15.8.5.3 Market Size and Forecast, By Storage Type
15.8.5.4 Market Size and Forecast, By Type of Biobank
15.8.5.5 Market Size and Forecast, By End-Use
15.8.5.6 Market Size and Forecast, By Application
15.8.6 Venezuela
15.8.6.1 Market Size and Forecast, ByProduct and Services
15.8.6.2 Market Size and Forecast, By Type of Biobank Type
15.8.6.3 Market Size and Forecast, By Storage Type
15.8.6.4 Market Size and Forecast, By Type of Biobank
15.8.6.5 Market Size and Forecast, By End-Use
15.8.6.6 Market Size and Forecast, By Application
15.8.7. Rest of Latin America
15.8.7.1 Market Size and Forecast, ByProduct and Services
15.8.7.2 Market Size and Forecast, By Type of Biobank Type
15.8.7.3 Market Size and Forecast, By Storage Type
15.8.7.4 Market Size and Forecast, By Type of Biobank
15.8.7.5 Market Size and Forecast, By End-Use
15.8.7.6 Market Size and Forecast, By Application
16 Middle East Biobanking Market Analysis and Forecast (2023-2030)
16.1 Introduction
16.2 Middle East Biobanking Market Share Analysis, ByProduct and Services
16.3 Middle East Biobanking Market Size and Forecast, By Type of Biobank Type
16.4 Middle East Biobanking Market Size and Forecast, By Storage Type
16.5 Middle East Biobanking Market Size and Forecast, By Type of Biobank
16.6 Middle East Biobanking Market Size and Forecast, By End-User
16.7 Middle East Biobanking Market Size and Forecast, By Application
16.8 Middle East Biobanking Market Size and Forecast, By Country
16.8.1. Saudi Arabia
16.8.1.1 Market Size and Forecast, ByProduct and Services
16.8.1.2 Market Size and Forecast, By Type of Biobank Type
16.8.1.3 Market Size and Forecast, By Storage Type
16.8.1.4 Market Size and Forecast, By Type of Biobank
16.8.1.5 Market Size and Forecast, By End-Use
16.8.1.6 Market Size and Forecast, By Application
16.8.2. UAE
16.8.2.1 Market Size and Forecast, ByProduct and Services
16.8.2.2 Market Size and Forecast, By Type of Biobank Type
16.8.2.3 Market Size and Forecast, By Storage Type
16.8.2.4 Market Size and Forecast, By Type of Biobank
16.8.2.5 Market Size and Forecast, By End-Use
16.8.2.6 Market Size and Forecast, By Application
16.8.3. Egypt
16.8.3.1 Market Size and Forecast, ByProduct and Services
16.8.3.2 Market Size and Forecast, By Type of Biobank Type
16.8.3.3 Market Size and Forecast, By Storage Type
16.8.3.4 Market Size and Forecast, By Type of Biobank
16.8.3.5 Market Size and Forecast, By End-Use
16.8.3.6 Market Size and Forecast, By Application
16.8.4. Kuwait
16.8.4.1 Market Size and Forecast, ByProduct and Services
16.8.4.2 Market Size and Forecast, By Type of Biobank Type
16.8.4.3 Market Size and Forecast, By Storage Type
16.8.4.4 Market Size and Forecast, By Type of Biobank
16.8.4.5 Market Size and Forecast, By End-Use
16.8.4.6 Market Size and Forecast, By Application
16.8.5. South Africa
16.8.5.1 Market Size and Forecast, ByProduct and Services
16.8.5.2 Market Size and Forecast, By Type of Biobank Type
16.8.5.3 Market Size and Forecast, By Storage Type
16.8.5.4 Market Size and Forecast, By Type of Biobank
16.8.5.5 Market Size and Forecast, By End-Use
16.8.5.6 Market Size and Forecast, By Application
16.8.6 Rest of Middle East & Africa
16.8.6.1 Market Size and Forecast, By Product and Services
16.8.6.2 Market Size and Forecast, By Type of Biobank Type
16.8.6.3 Market Size and Forecast, By Storage Type
16.8.6.4 Market Size and Forecast, By Type of Biobank
16.8.6.5 Market Size and Forecast, By End-Use
16.8.6.6 Market Size and Forecast, By Application
17 Competitive Analysis
17.1 Competition Dashboard
17.2 Market share Analysis of Top Vendors
17.3 Key Development Strategies
18 Company Profiles
18.1Thermo Fisher Scientific Inc.
18.1.1 Overview
18.1.2 Offerings
18.1.3 Key Financials
18.1.4 Business Segment & Geographic Overview
18.1.5 Key Market Developments
18.1.6 Key Strategies
18.2 Tecan Trading AG
18.2.1 Overview
18.2.2 Offerings
18.2.3 Key Financials
18.2.4 Business Segment & Geographic Overview
18.2.5 Key Market Developments
18.2.6 Key Strategies
18.3 QIAGEN
18.3.1 Overview
18.3.2 Offerings
18.3.3 Key Financials
18.3.4 Business Segment & Geographic Overview
18.3.5 Key Market Developments
18.3.6 Key Strategies
18.4 Hamilton Company
18.4.1 Overview
18.4.2 Offerings
18.4.3 Key Financials
18.4.4 Business Segment & Geographic Overview
18.4.5 Key Market Developments
18.4.6 Key Strategies
18.5 Brooks Life Sciences
18.5.1 Overview
18.5.2 Offerings
18.5.3 Key Financials
18.5.4 Business Segment & Geographic Overview
18.5.5 Key Market Developments
18.5.6 Key Strategies
18.6 TTP Labtech
18.6.1 Overview
18.6.2 Offerings
18.6.3 Key Financials
18.6.4 Business Segment & Geographic Overview
18.6.5 Key Market Developments
18.6.6 Key Strategies
18.7 VWR International, LLC
18.7.1 Overview
18.7.2 Offerings
18.7.3 Key Financials
18.7.4 Business Segment & Geographic Overview
18.7.5 Key Market Developments
18.7.6 Key Strategies
18.8 Promega Corporation
18.8.1 Overview
18.8.2 Offerings
18.8.3 Key Financials
18.8.4 Business Segment & Geographic Overview
18.8.5 Key Market Developments
18.8.6 Key Strategies
18.9 Worthington Industries
18.9.1 Overview
18.9.2 Offerings
18.9.3 Key Financials
18.9.4 Business Segment & Geographic Overview
18.9.5 Key Market Developments
18.9.6 Key Strategies
18.10 BD
18.10.1 Overview
18.10.2 Offerings
18.10.3 Key Financials
18.10.4 Business Segment & Geographic Overview
18.10.5 Key Market Developments
18.10.6 Key Strategies